No evidence for persistence of BCR-ABL-positive cells in patients in molecular remission after conventional allogenic transplantation for chronic myeloid leukemia

MLA

M, Deininger, et al. “No Evidence for Persistence of BCR-ABL-Positive Cells in Patients in Molecular Remission after Conventional Allogenic Transplantation for Chronic Myeloid Leukemia.” Blood, vol. 96, no. 2, Aug. 2000. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........e18d65d2cdbf4790430f324e1a71234d&authtype=sso&custid=ns315887.

APA

M, D., T, L., R, K., E, H., C, M., & D, N. (2000). No evidence for persistence of BCR-ABL-positive cells in patients in molecular remission after conventional allogenic transplantation for chronic myeloid leukemia. Blood, 96(2).

Chicago

M, Deininger, Lehmann T, Krahl R, Hennig E, Müller C, and Niederwieser D. 2000. “No Evidence for Persistence of BCR-ABL-Positive Cells in Patients in Molecular Remission after Conventional Allogenic Transplantation for Chronic Myeloid Leukemia.” Blood 96 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........e18d65d2cdbf4790430f324e1a71234d&authtype=sso&custid=ns315887.